Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Peritoneal Neoplasms | 34 | 2024 | 711 | 5.700 |
Why?
|
Hyperthermia, Induced | 27 | 2024 | 417 | 4.740 |
Why?
|
Appendiceal Neoplasms | 13 | 2022 | 155 | 3.310 |
Why?
|
Carcinoma, Hepatocellular | 19 | 2024 | 2297 | 3.040 |
Why?
|
Liver Neoplasms | 24 | 2024 | 4319 | 2.920 |
Why?
|
Chemotherapy, Cancer, Regional Perfusion | 14 | 2022 | 94 | 2.480 |
Why?
|
Hepatectomy | 12 | 2020 | 557 | 1.890 |
Why?
|
Gallbladder Neoplasms | 7 | 2024 | 189 | 1.520 |
Why?
|
Adenocarcinoma, Mucinous | 7 | 2020 | 517 | 1.350 |
Why?
|
Mitomycin | 3 | 2017 | 263 | 1.150 |
Why?
|
Cholecystectomy | 3 | 2024 | 406 | 1.020 |
Why?
|
Colorectal Neoplasms | 14 | 2024 | 6935 | 0.960 |
Why?
|
Pseudomyxoma Peritonei | 3 | 2019 | 21 | 0.960 |
Why?
|
Hepatitis B, Chronic | 4 | 2021 | 410 | 0.960 |
Why?
|
Emigrants and Immigrants | 3 | 2021 | 543 | 0.930 |
Why?
|
Combined Modality Therapy | 29 | 2024 | 8528 | 0.880 |
Why?
|
Stomach Neoplasms | 7 | 2024 | 1459 | 0.800 |
Why?
|
Pancreatic Neoplasms | 12 | 2023 | 5369 | 0.780 |
Why?
|
Gastrectomy | 3 | 2024 | 672 | 0.770 |
Why?
|
Adenocarcinoma | 13 | 2023 | 6346 | 0.770 |
Why?
|
Adenocarcinoma, Papillary | 2 | 2022 | 84 | 0.750 |
Why?
|
Neoplasms, Multiple Primary | 2 | 2019 | 592 | 0.740 |
Why?
|
Hepatitis B | 3 | 2021 | 705 | 0.710 |
Why?
|
Laparoscopy | 9 | 2024 | 2036 | 0.710 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2024 | 617 | 0.620 |
Why?
|
Survival Rate | 27 | 2024 | 12725 | 0.590 |
Why?
|
Neoplasm Recurrence, Local | 14 | 2023 | 9280 | 0.580 |
Why?
|
Neoplasm Staging | 16 | 2024 | 11121 | 0.570 |
Why?
|
Diaphragm | 2 | 2019 | 351 | 0.560 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 1 | 2019 | 194 | 0.560 |
Why?
|
Leukopenia | 1 | 2017 | 213 | 0.560 |
Why?
|
Liver Cirrhosis | 5 | 2024 | 1935 | 0.550 |
Why?
|
Prognosis | 30 | 2024 | 29629 | 0.550 |
Why?
|
Carcinoma, Pancreatic Ductal | 4 | 2023 | 1728 | 0.540 |
Why?
|
Ablation Techniques | 2 | 2016 | 248 | 0.530 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 19 | 2024 | 11742 | 0.510 |
Why?
|
Antibiotics, Antineoplastic | 2 | 2017 | 678 | 0.510 |
Why?
|
Cholangiocarcinoma | 3 | 2023 | 552 | 0.500 |
Why?
|
Bile Duct Neoplasms | 3 | 2023 | 605 | 0.500 |
Why?
|
Chemoembolization, Therapeutic | 1 | 2016 | 128 | 0.490 |
Why?
|
Retrospective Studies | 51 | 2024 | 80646 | 0.480 |
Why?
|
New York City | 7 | 2021 | 731 | 0.460 |
Why?
|
Pain, Postoperative | 1 | 2024 | 1740 | 0.450 |
Why?
|
Lymphocytes | 2 | 2021 | 2612 | 0.450 |
Why?
|
Niacinamide | 1 | 2016 | 413 | 0.450 |
Why?
|
Laparoscopes | 1 | 2012 | 37 | 0.430 |
Why?
|
Phenylurea Compounds | 1 | 2016 | 529 | 0.420 |
Why?
|
Cautery | 1 | 2012 | 71 | 0.410 |
Why?
|
Neoplasm Regression, Spontaneous | 1 | 2012 | 46 | 0.410 |
Why?
|
Neutropenia | 1 | 2017 | 885 | 0.400 |
Why?
|
Hemostasis, Surgical | 1 | 2012 | 126 | 0.400 |
Why?
|
Middle Aged | 59 | 2024 | 220920 | 0.400 |
Why?
|
Monocytes | 1 | 2021 | 2570 | 0.390 |
Why?
|
Tumor Burden | 2 | 2021 | 1893 | 0.390 |
Why?
|
Healthcare Disparities | 2 | 2018 | 3358 | 0.370 |
Why?
|
Social Class | 2 | 2018 | 2004 | 0.370 |
Why?
|
Research Subjects | 1 | 2013 | 249 | 0.360 |
Why?
|
Carcinoma | 4 | 2019 | 2330 | 0.360 |
Why?
|
Hepatitis C | 1 | 2021 | 1584 | 0.360 |
Why?
|
Sutures | 1 | 2012 | 284 | 0.360 |
Why?
|
Cryoglobulinemia | 1 | 2010 | 84 | 0.350 |
Why?
|
Neoplasms, Fibrous Tissue | 1 | 2010 | 20 | 0.350 |
Why?
|
Aged | 46 | 2024 | 169310 | 0.340 |
Why?
|
Humans | 103 | 2024 | 761572 | 0.330 |
Why?
|
Male | 64 | 2024 | 360842 | 0.330 |
Why?
|
Colectomy | 1 | 2014 | 688 | 0.330 |
Why?
|
Quality Indicators, Health Care | 1 | 2019 | 1792 | 0.330 |
Why?
|
Pancreatectomy | 4 | 2023 | 811 | 0.320 |
Why?
|
Lymph Node Excision | 4 | 2024 | 1271 | 0.310 |
Why?
|
Female | 66 | 2024 | 392686 | 0.310 |
Why?
|
Carcinoma, Signet Ring Cell | 2 | 2019 | 82 | 0.300 |
Why?
|
Analgesics, Opioid | 1 | 2024 | 3808 | 0.300 |
Why?
|
Residence Characteristics | 1 | 2018 | 2094 | 0.290 |
Why?
|
Practice Guidelines as Topic | 4 | 2021 | 7391 | 0.280 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2012 | 621 | 0.280 |
Why?
|
Fibrin Tissue Adhesive | 1 | 2007 | 86 | 0.270 |
Why?
|
Guideline Adherence | 1 | 2017 | 2220 | 0.270 |
Why?
|
Program Development | 1 | 2012 | 1297 | 0.270 |
Why?
|
Vasculitis | 1 | 2010 | 521 | 0.260 |
Why?
|
Follow-Up Studies | 16 | 2024 | 39107 | 0.260 |
Why?
|
Kaplan-Meier Estimate | 6 | 2021 | 6484 | 0.260 |
Why?
|
Carcinoma in Situ | 2 | 2022 | 791 | 0.260 |
Why?
|
Adult | 39 | 2024 | 221203 | 0.250 |
Why?
|
Health Status Disparities | 2 | 2014 | 1852 | 0.250 |
Why?
|
Androgen-Insensitivity Syndrome | 1 | 2005 | 33 | 0.250 |
Why?
|
Rectal Prolapse | 1 | 2005 | 33 | 0.240 |
Why?
|
Incidental Findings | 1 | 2010 | 697 | 0.240 |
Why?
|
Patient Acceptance of Health Care | 1 | 2018 | 3205 | 0.240 |
Why?
|
Pancreaticoduodenectomy | 4 | 2023 | 509 | 0.230 |
Why?
|
Aftercare | 2 | 2022 | 914 | 0.230 |
Why?
|
New York | 4 | 2022 | 874 | 0.230 |
Why?
|
Liver Transplantation | 1 | 2016 | 2330 | 0.230 |
Why?
|
Treatment Outcome | 18 | 2024 | 64684 | 0.230 |
Why?
|
Cefoxitin | 1 | 2023 | 35 | 0.220 |
Why?
|
Bandages | 1 | 2005 | 269 | 0.220 |
Why?
|
Students, Medical | 3 | 2013 | 1936 | 0.220 |
Why?
|
Postoperative Hemorrhage | 1 | 2007 | 415 | 0.210 |
Why?
|
Overnutrition | 1 | 2022 | 25 | 0.210 |
Why?
|
Chemotherapy, Adjuvant | 6 | 2021 | 3514 | 0.210 |
Why?
|
Hepatitis C, Chronic | 1 | 2010 | 1032 | 0.200 |
Why?
|
Laparotomy | 1 | 2024 | 457 | 0.200 |
Why?
|
Hernia, Inguinal | 1 | 2005 | 220 | 0.200 |
Why?
|
Education, Medical | 2 | 2013 | 1725 | 0.200 |
Why?
|
Hypophosphatemia | 1 | 2022 | 92 | 0.190 |
Why?
|
Digestive System Surgical Procedures | 2 | 2018 | 572 | 0.190 |
Why?
|
Neoplasm Invasiveness | 5 | 2020 | 3597 | 0.190 |
Why?
|
Calcinosis | 1 | 2010 | 1469 | 0.190 |
Why?
|
Health Services Accessibility | 1 | 2018 | 5440 | 0.180 |
Why?
|
Biliary Tract Surgical Procedures | 1 | 2020 | 45 | 0.180 |
Why?
|
Water-Electrolyte Imbalance | 1 | 2022 | 109 | 0.180 |
Why?
|
Colon | 3 | 2020 | 1792 | 0.180 |
Why?
|
Jaundice | 1 | 2020 | 94 | 0.180 |
Why?
|
Dehydration | 1 | 2022 | 216 | 0.180 |
Why?
|
Aged, 80 and over | 16 | 2022 | 58986 | 0.170 |
Why?
|
Sepsis | 3 | 2023 | 2585 | 0.170 |
Why?
|
Carcinoma, Adenosquamous | 1 | 2020 | 66 | 0.170 |
Why?
|
Digestive System Neoplasms | 1 | 2020 | 82 | 0.170 |
Why?
|
Rectum | 1 | 2005 | 892 | 0.170 |
Why?
|
Survival Analysis | 4 | 2021 | 10090 | 0.170 |
Why?
|
Multivariate Analysis | 3 | 2021 | 12059 | 0.170 |
Why?
|
Logistic Models | 4 | 2017 | 13255 | 0.170 |
Why?
|
Chi-Square Distribution | 3 | 2016 | 3416 | 0.170 |
Why?
|
Postoperative Complications | 10 | 2024 | 15633 | 0.170 |
Why?
|
Vagina | 1 | 2005 | 838 | 0.160 |
Why?
|
Platelet Count | 2 | 2012 | 781 | 0.160 |
Why?
|
Superinfection | 1 | 2019 | 63 | 0.160 |
Why?
|
Health Care Reform | 1 | 2008 | 1247 | 0.160 |
Why?
|
Disease-Free Survival | 3 | 2019 | 6815 | 0.160 |
Why?
|
Carcinoembryonic Antigen | 1 | 2019 | 337 | 0.150 |
Why?
|
Ileum | 2 | 2014 | 557 | 0.150 |
Why?
|
Risk Factors | 9 | 2024 | 74213 | 0.150 |
Why?
|
Leukocyte Count | 1 | 2021 | 1596 | 0.140 |
Why?
|
Mass Screening | 2 | 2021 | 5428 | 0.140 |
Why?
|
Malnutrition | 1 | 2023 | 645 | 0.140 |
Why?
|
CA-125 Antigen | 1 | 2019 | 281 | 0.140 |
Why?
|
Research Design | 1 | 2013 | 6180 | 0.140 |
Why?
|
Preventive Health Services | 1 | 2022 | 567 | 0.140 |
Why?
|
Digestive System Diseases | 1 | 2018 | 151 | 0.140 |
Why?
|
Proctocolectomy, Restorative | 2 | 2009 | 190 | 0.140 |
Why?
|
End Stage Liver Disease | 1 | 2021 | 352 | 0.140 |
Why?
|
Antineoplastic Agents | 5 | 2019 | 13642 | 0.130 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2024 | 1745 | 0.130 |
Why?
|
Neoplasms | 4 | 2023 | 22173 | 0.130 |
Why?
|
Surgical Wound Infection | 2 | 2023 | 1529 | 0.130 |
Why?
|
Wound Healing | 1 | 2007 | 2805 | 0.130 |
Why?
|
Lymphatic Metastasis | 4 | 2023 | 2915 | 0.130 |
Why?
|
Gastrointestinal Neoplasms | 2 | 2020 | 954 | 0.130 |
Why?
|
Time Factors | 8 | 2019 | 39970 | 0.120 |
Why?
|
Focus Groups | 2 | 2018 | 1413 | 0.120 |
Why?
|
Intention to Treat Analysis | 1 | 2016 | 413 | 0.120 |
Why?
|
Insulinoma | 1 | 2015 | 121 | 0.120 |
Why?
|
Prospective Studies | 9 | 2024 | 54426 | 0.120 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2024 | 2917 | 0.110 |
Why?
|
Hepacivirus | 1 | 2021 | 1336 | 0.110 |
Why?
|
Respiratory Insufficiency | 1 | 2022 | 1230 | 0.110 |
Why?
|
Intestine, Large | 1 | 2013 | 68 | 0.110 |
Why?
|
Young Adult | 9 | 2019 | 59255 | 0.110 |
Why?
|
Receptors, Lymphocyte Homing | 1 | 2013 | 141 | 0.110 |
Why?
|
Neuroendocrine Tumors | 1 | 2019 | 641 | 0.110 |
Why?
|
Quality of Health Care | 1 | 2008 | 4330 | 0.100 |
Why?
|
Student Dropouts | 1 | 2012 | 27 | 0.100 |
Why?
|
Proportional Hazards Models | 3 | 2018 | 12463 | 0.100 |
Why?
|
Socioeconomic Factors | 3 | 2016 | 7827 | 0.100 |
Why?
|
Intracranial Hemorrhages | 1 | 2018 | 822 | 0.100 |
Why?
|
Risk Assessment | 7 | 2023 | 23996 | 0.100 |
Why?
|
Age Factors | 5 | 2019 | 18398 | 0.100 |
Why?
|
Urogenital Neoplasms | 1 | 2013 | 131 | 0.100 |
Why?
|
Pancreas | 1 | 2019 | 1691 | 0.100 |
Why?
|
Needs Assessment | 2 | 2022 | 1139 | 0.100 |
Why?
|
Receptors, Peptide | 1 | 2013 | 279 | 0.100 |
Why?
|
Ethics Committees, Research | 1 | 2013 | 196 | 0.100 |
Why?
|
Endosonography | 1 | 2015 | 609 | 0.090 |
Why?
|
Neoadjuvant Therapy | 4 | 2023 | 2827 | 0.090 |
Why?
|
Gene Regulatory Networks | 1 | 2019 | 1745 | 0.090 |
Why?
|
Foreign Bodies | 1 | 2014 | 402 | 0.090 |
Why?
|
Surgical Procedures, Operative | 1 | 2022 | 1924 | 0.090 |
Why?
|
Equipment Failure Analysis | 1 | 2012 | 847 | 0.090 |
Why?
|
Technology Assessment, Biomedical | 1 | 2012 | 307 | 0.090 |
Why?
|
Patient Readmission | 2 | 2022 | 3271 | 0.090 |
Why?
|
Pneumonectomy | 1 | 2017 | 1119 | 0.090 |
Why?
|
Delivery of Health Care | 1 | 2008 | 5336 | 0.090 |
Why?
|
Anastomotic Leak | 2 | 2022 | 163 | 0.080 |
Why?
|
International Normalized Ratio | 1 | 2011 | 382 | 0.080 |
Why?
|
Bilirubin | 1 | 2011 | 436 | 0.080 |
Why?
|
Computer-Assisted Instruction | 1 | 2012 | 362 | 0.080 |
Why?
|
Ethanol | 1 | 2015 | 1324 | 0.080 |
Why?
|
Capitalism | 1 | 2008 | 16 | 0.080 |
Why?
|
Propensity Score | 1 | 2016 | 1913 | 0.080 |
Why?
|
Serum Albumin | 1 | 2011 | 672 | 0.080 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2014 | 874 | 0.080 |
Why?
|
National Health Insurance, United States | 1 | 2008 | 100 | 0.070 |
Why?
|
Single-Payer System | 1 | 2008 | 35 | 0.070 |
Why?
|
Vaginal Neoplasms | 1 | 2008 | 104 | 0.070 |
Why?
|
Hospital Volunteers | 1 | 2007 | 5 | 0.070 |
Why?
|
Incidence | 3 | 2023 | 21355 | 0.070 |
Why?
|
Stomach Ulcer | 1 | 2007 | 122 | 0.070 |
Why?
|
Ultrasonography, Interventional | 1 | 2015 | 1496 | 0.070 |
Why?
|
Early Detection of Cancer | 1 | 2021 | 3201 | 0.070 |
Why?
|
Prevalence | 2 | 2021 | 15732 | 0.070 |
Why?
|
Telemedicine | 1 | 2024 | 3052 | 0.070 |
Why?
|
Tumor Microenvironment | 1 | 2019 | 3877 | 0.070 |
Why?
|
Colitis, Ulcerative | 2 | 2009 | 1922 | 0.070 |
Why?
|
Intestinal Neoplasms | 1 | 2009 | 312 | 0.070 |
Why?
|
Carrier Proteins | 1 | 2019 | 4937 | 0.070 |
Why?
|
Unemployment | 1 | 2008 | 210 | 0.070 |
Why?
|
Hemostatic Techniques | 1 | 2007 | 112 | 0.060 |
Why?
|
User-Computer Interface | 1 | 2012 | 1400 | 0.060 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2013 | 1250 | 0.060 |
Why?
|
Infusions, Parenteral | 2 | 2016 | 397 | 0.060 |
Why?
|
Patient Selection | 4 | 2021 | 4244 | 0.060 |
Why?
|
Rectovaginal Fistula | 1 | 2005 | 12 | 0.060 |
Why?
|
Tissue Adhesives | 1 | 2007 | 173 | 0.060 |
Why?
|
Brain Ischemia | 1 | 2018 | 3049 | 0.060 |
Why?
|
Monitoring, Intraoperative | 1 | 2011 | 942 | 0.060 |
Why?
|
Biopsy, Needle | 1 | 2010 | 1626 | 0.060 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2020 | 4026 | 0.060 |
Why?
|
Equipment Design | 1 | 2012 | 3511 | 0.060 |
Why?
|
Anus Neoplasms | 1 | 2008 | 329 | 0.060 |
Why?
|
Body Weights and Measures | 1 | 2005 | 208 | 0.060 |
Why?
|
Reoperation | 1 | 2014 | 4303 | 0.060 |
Why?
|
Hemostatics | 1 | 2007 | 241 | 0.060 |
Why?
|
Ovarian Neoplasms | 3 | 2019 | 4878 | 0.060 |
Why?
|
Minority Groups | 1 | 2011 | 1203 | 0.060 |
Why?
|
Adolescent | 4 | 2017 | 88324 | 0.060 |
Why?
|
Recurrence | 1 | 2016 | 8466 | 0.060 |
Why?
|
Piperacillin | 1 | 2023 | 37 | 0.050 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2019 | 8552 | 0.050 |
Why?
|
Penicillanic Acid | 1 | 2023 | 42 | 0.050 |
Why?
|
Phenotype | 1 | 2021 | 16592 | 0.050 |
Why?
|
Medically Uninsured | 1 | 2008 | 836 | 0.050 |
Why?
|
United States | 4 | 2018 | 72335 | 0.050 |
Why?
|
Fundoplication | 1 | 2003 | 144 | 0.050 |
Why?
|
Pancreatic Fistula | 1 | 2023 | 148 | 0.050 |
Why?
|
Databases, Factual | 4 | 2019 | 7967 | 0.050 |
Why?
|
Prealbumin | 1 | 2023 | 222 | 0.050 |
Why?
|
Intestinal Mucosa | 1 | 2013 | 3032 | 0.050 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2023 | 296 | 0.050 |
Why?
|
Peritoneum | 1 | 2022 | 225 | 0.050 |
Why?
|
Clinical Competence | 2 | 2019 | 4793 | 0.050 |
Why?
|
Edema | 1 | 2005 | 766 | 0.050 |
Why?
|
Disease Progression | 1 | 2018 | 13510 | 0.050 |
Why?
|
Blood Transfusion | 2 | 2020 | 1301 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 3 | 2019 | 20571 | 0.040 |
Why?
|
Inflammation | 2 | 2022 | 10773 | 0.040 |
Why?
|
Rural Health Services | 1 | 2024 | 384 | 0.040 |
Why?
|
Aspartate Aminotransferases | 1 | 2022 | 416 | 0.040 |
Why?
|
Common Bile Duct | 1 | 2020 | 106 | 0.040 |
Why?
|
Diagnosis, Differential | 2 | 2019 | 12975 | 0.040 |
Why?
|
Creatine Kinase | 1 | 2022 | 685 | 0.040 |
Why?
|
Mutation | 1 | 2024 | 30054 | 0.040 |
Why?
|
Patient Satisfaction | 1 | 2012 | 3461 | 0.040 |
Why?
|
Omentum | 1 | 2020 | 168 | 0.040 |
Why?
|
Liver | 3 | 2022 | 7529 | 0.040 |
Why?
|
Sex Factors | 2 | 2011 | 10553 | 0.040 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2013 | 3080 | 0.040 |
Why?
|
Regression Analysis | 1 | 2009 | 6344 | 0.040 |
Why?
|
Uganda | 1 | 2024 | 1332 | 0.040 |
Why?
|
Pleural Effusion, Malignant | 1 | 2020 | 106 | 0.040 |
Why?
|
Odds Ratio | 1 | 2011 | 9646 | 0.040 |
Why?
|
Chest Tubes | 1 | 2019 | 152 | 0.040 |
Why?
|
Attitude of Health Personnel | 1 | 2013 | 3889 | 0.040 |
Why?
|
Gastric Bypass | 1 | 2007 | 818 | 0.040 |
Why?
|
Phosphates | 1 | 2022 | 770 | 0.040 |
Why?
|
Frail Elderly | 1 | 2023 | 765 | 0.040 |
Why?
|
Perioperative Period | 1 | 2019 | 250 | 0.040 |
Why?
|
International Cooperation | 1 | 2024 | 1422 | 0.040 |
Why?
|
Length of Stay | 3 | 2024 | 6426 | 0.040 |
Why?
|
Reference Values | 1 | 2005 | 4920 | 0.040 |
Why?
|
Learning Curve | 1 | 2019 | 230 | 0.040 |
Why?
|
Skilled Nursing Facilities | 1 | 2022 | 398 | 0.040 |
Why?
|
Severity of Illness Index | 1 | 2015 | 15843 | 0.040 |
Why?
|
Case-Control Studies | 2 | 2013 | 22176 | 0.040 |
Why?
|
Child, Preschool | 3 | 2012 | 42230 | 0.040 |
Why?
|
Duodenum | 1 | 2020 | 490 | 0.040 |
Why?
|
Morbidity | 1 | 2022 | 1750 | 0.030 |
Why?
|
Abscess | 1 | 2020 | 606 | 0.030 |
Why?
|
Receptors, Immunologic | 1 | 2022 | 1410 | 0.030 |
Why?
|
Obesity, Morbid | 1 | 2007 | 1277 | 0.030 |
Why?
|
Cross-Sectional Studies | 2 | 2014 | 26127 | 0.030 |
Why?
|
Blood Loss, Surgical | 1 | 2020 | 638 | 0.030 |
Why?
|
Immunohistochemistry | 1 | 2010 | 11076 | 0.030 |
Why?
|
Stroke | 1 | 2018 | 9758 | 0.030 |
Why?
|
Infant, Newborn | 3 | 2005 | 26198 | 0.030 |
Why?
|
Gastroesophageal Reflux | 1 | 2003 | 819 | 0.030 |
Why?
|
General Surgery | 1 | 2007 | 1692 | 0.030 |
Why?
|
Stomach | 1 | 2019 | 696 | 0.030 |
Why?
|
Home Care Services | 1 | 2022 | 648 | 0.030 |
Why?
|
Smoking | 1 | 2011 | 9053 | 0.030 |
Why?
|
Developing Countries | 1 | 2007 | 2885 | 0.030 |
Why?
|
HIV Infections | 1 | 2021 | 17352 | 0.030 |
Why?
|
Intraoperative Complications | 1 | 2020 | 1166 | 0.030 |
Why?
|
Drainage | 1 | 2019 | 1157 | 0.030 |
Why?
|
Citrobacter rodentium | 1 | 2013 | 65 | 0.030 |
Why?
|
Lung Diseases | 1 | 2003 | 1909 | 0.030 |
Why?
|
Patient Admission | 1 | 2020 | 1367 | 0.030 |
Why?
|
Intestinal Perforation | 1 | 2014 | 249 | 0.030 |
Why?
|
Anti-Bacterial Agents | 2 | 2023 | 7407 | 0.030 |
Why?
|
Melanoma | 1 | 2011 | 5709 | 0.030 |
Why?
|
Organoplatinum Compounds | 1 | 2014 | 407 | 0.030 |
Why?
|
Membrane Glycoproteins | 1 | 2022 | 3701 | 0.020 |
Why?
|
Medicine, Chinese Traditional | 1 | 2012 | 73 | 0.020 |
Why?
|
Decision Making, Computer-Assisted | 1 | 2012 | 146 | 0.020 |
Why?
|
Child | 3 | 2012 | 80156 | 0.020 |
Why?
|
Hepatitis B virus | 1 | 2015 | 528 | 0.020 |
Why?
|
Skin Neoplasms | 1 | 2011 | 5821 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2023 | 3466 | 0.020 |
Why?
|
Enterobacteriaceae Infections | 1 | 2013 | 188 | 0.020 |
Why?
|
Hospitals, Private | 1 | 2011 | 63 | 0.020 |
Why?
|
Qualitative Research | 1 | 2021 | 3023 | 0.020 |
Why?
|
Camptothecin | 1 | 2014 | 591 | 0.020 |
Why?
|
Intraoperative Care | 1 | 2014 | 767 | 0.020 |
Why?
|
Hospitals, Public | 1 | 2011 | 202 | 0.020 |
Why?
|
Helicobacter Infections | 1 | 2013 | 388 | 0.020 |
Why?
|
Metagenome | 1 | 2013 | 450 | 0.020 |
Why?
|
New England | 1 | 2012 | 1054 | 0.020 |
Why?
|
Communication Barriers | 1 | 2012 | 413 | 0.020 |
Why?
|
Patient Discharge | 1 | 2022 | 3443 | 0.020 |
Why?
|
Colonic Pouches | 1 | 2009 | 122 | 0.020 |
Why?
|
Computational Biology | 1 | 2019 | 3517 | 0.020 |
Why?
|
Biopsy | 1 | 2019 | 6766 | 0.020 |
Why?
|
Intestine, Small | 1 | 2013 | 1206 | 0.020 |
Why?
|
Internship and Residency | 1 | 2007 | 5882 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2020 | 3744 | 0.020 |
Why?
|
Quality Improvement | 1 | 2022 | 3801 | 0.020 |
Why?
|
Abdomen | 1 | 2012 | 1128 | 0.020 |
Why?
|
Physical Examination | 1 | 2012 | 1255 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2019 | 3801 | 0.020 |
Why?
|
China | 1 | 2012 | 2374 | 0.020 |
Why?
|
Schools, Medical | 1 | 2012 | 879 | 0.020 |
Why?
|
Anastomosis, Surgical | 1 | 2009 | 983 | 0.020 |
Why?
|
Educational Measurement | 1 | 2012 | 1255 | 0.020 |
Why?
|
Altruism | 1 | 2007 | 208 | 0.020 |
Why?
|
Gastric Mucosa | 1 | 2008 | 604 | 0.020 |
Why?
|
Cohort Studies | 2 | 2019 | 41493 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2012 | 36429 | 0.010 |
Why?
|
Comorbidity | 2 | 2013 | 10508 | 0.010 |
Why?
|
Colitis | 1 | 2013 | 1233 | 0.010 |
Why?
|
Blood Platelets | 1 | 2015 | 2479 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2015 | 5247 | 0.010 |
Why?
|
Immune Tolerance | 1 | 2013 | 2302 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2019 | 10448 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2018 | 3530 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2008 | 1835 | 0.010 |
Why?
|
Education, Medical, Undergraduate | 1 | 2012 | 1070 | 0.010 |
Why?
|
Job Satisfaction | 1 | 2007 | 544 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2019 | 16986 | 0.010 |
Why?
|
Infant | 1 | 2005 | 36192 | 0.010 |
Why?
|
Neutrophils | 1 | 2015 | 3767 | 0.010 |
Why?
|
Homeostasis | 1 | 2013 | 3323 | 0.010 |
Why?
|
Patient Education as Topic | 1 | 2012 | 2319 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2013 | 9541 | 0.010 |
Why?
|
Obesity | 1 | 2022 | 12947 | 0.010 |
Why?
|
Insurance, Health | 1 | 2011 | 2498 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2013 | 14416 | 0.010 |
Why?
|
Algorithms | 1 | 2015 | 14032 | 0.010 |
Why?
|
Infant, Premature | 1 | 2003 | 2107 | 0.010 |
Why?
|
Body Weight | 1 | 2003 | 4618 | 0.010 |
Why?
|
Mice | 1 | 2013 | 81533 | 0.000 |
Why?
|
Animals | 1 | 2013 | 168467 | 0.000 |
Why?
|